TrialWorld journal of nephrology2025

Sucroferric oxyhydroxide monotherapy for hyperphosphatemia in Indian chronic kidney disease patients undergoing hemodialysis: A phase IV, single-arm, open-label study.

M R Niranjan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.